We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+20.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$238M
AUM Growth
+$62.2M
Cap. Flow
+$72.9M
Cap. Flow %
30.65%
Top 10 Hldgs %
3.98%
Holding
1,009
New
415
Increased
187
Reduced
92
Closed
315

Sector Composition

Rank Sector Weight
1 Technology 18.55%
2 Healthcare 17.08%
3 Industrials 16.7%
4 Financials 10.96%
5 Consumer Discretionary 10.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADAM
651
Adamas Trust
ADAM
$777M
$127K 0.05%
+20,938
New +$123K
ERIC icon
652
Ericsson
ERIC
$30.7B
$127K 0.05%
+15,729
New +$128K
KEP icon
653
Korea Electric Power
KEP
$15.5B
$126K 0.05%
+18,385
New +$144K
PAGS icon
654
PagSeguro Digital
PAGS
$2.57B
$122K 0.05%
+19,525
New +$150K
WTI icon
655
W&T Offshore
WTI
$545M
$120K 0.05%
72,572
+20,946
+41% +$41.9K
POET icon
656
POET Technologies
POET
$1.19B
$119K 0.05%
+20,042
New +$88.9K
JMIA
657
Jumia Technologies
JMIA
$726M
$117K 0.05%
30,653
-9,172
-23% -$41.2K
TLS icon
658
Telos
TLS
$337M
$117K 0.05%
+34,229
New +$122K
OLPX
659
DELISTED
Olaplex Holdings
OLPX
$111K 0.05%
64,443
-4,651
-7% -$9.26K
NUS icon
660
Nu Skin
NUS
$247M
$110K 0.05%
15,901
-1,060
-6% -$7.29K
VALE icon
661
Vale
VALE
$62.9B
$109K 0.05%
+12,304
New +$125K
SWIM icon
662
Latham Group
SWIM
$646M
$109K 0.05%
+15,599
New +$104K
ASX icon
663
ASE Group
ASX
$80.8B
$107K 0.04%
10,586
-14,243
-57% -$142K
TSHA icon
664
Taysha Gene Therapies
TSHA
$1.59B
$106K 0.04%
61,495
+34,468
+128% +$71.5K
GT icon
665
Goodyear
GT
$2.07B
$104K 0.04%
+11,525
New +$105K
VISN
666
Vistance Networks Inc
VISN
$2.66B
$104K 0.04%
19,903
-3,698
-16% -$20.7K
LILAK icon
667
Liberty Latin America Class C
LILAK
$1.5B
$102K 0.04%
+17,720
New +$129K
MG icon
668
Mistras Group
MG
$492M
$102K 0.04%
+11,264
New +$111K
RDFN
669
DELISTED
Redfin
RDFN
$99.3K 0.04%
12,614
-5,843
-32% -$56.7K
KALV
670
DELISTED
KalVista Pharmaceuticals
KALV
$97.5K 0.04%
11,509
-12,813
-53% -$133K
RGNX icon
671
Regenxbio
RGNX
$623M
$96.9K 0.04%
+12,538
New +$118K
PL icon
672
Planet Labs
PL
$7.3B
$96.1K 0.04%
+23,793
New +$73.9K
VMD icon
673
Viemed Healthcare
VMD
$451M
$92K 0.04%
+11,474
New +$99.5K
RLAY icon
674
Relay Therapeutics
RLAY
$4.02B
$92K 0.04%
22,325
-4,043
-15% -$22K
CYRX icon
675
CryoPort
CYRX
$775M
$86.1K 0.04%
11,061
-10,122
-48% -$75.5K

Similar funds

EntryPoint Capital's Q4 2024 Portfolio in Review

As of Q4 2024, EntryPoint Capital held 1,009 positions worth $238M, up 35% from $176M the previous quarter. Its ten largest holdings account for 4% of the portfolio.

EntryPoint Capital deployed $72.9M of net new capital in Q4 2024, opening 415 new positions and adding to 187 existing holdings. Its largest new stake was Harmony Biosciences: 32,084 shares worth $1.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Matrix Service, an estimated $557K trimmed.

  • EntryPoint Capital's largest Q4 2024 buy was Harmony Biosciences: 32,084 shares worth $1.1M.
  • EntryPoint Capital added most to Viasat in Q4 2024, an estimated $846K increase.
  • EntryPoint Capital's biggest Q4 2024 reduction was Matrix Service, cutting an estimated $557K.
  • EntryPoint Capital fully exited Photronics in Q4 2024, selling an estimated $792K.
  • EntryPoint Capital's ten largest holdings make up 4% of its $238M portfolio in Q4 2024.
  • EntryPoint Capital opened 415 new positions and closed 315 in Q4 2024.
  • EntryPoint Capital's portfolio value rose 35% quarter-over-quarter to $238M.

Based on EntryPoint Capital's 13F filing for Q4 2024, filed 11 Feb 2025.